A study conducted by researchers at the University of Waterloo highlights the negative impact of antipsychotic medications on nursing home residents, particularly when used off-label for symptoms related to dementia. Analyzing data from nearly 500,000 Canadian residents between 2000 and 2022, the study revealed that 68% of those prescribed antipsychotics exhibited worsening behavioral issues. These medications, often used to manage agitation and aggression in dementia patients, are primarily approved for other disorders, leading to risky side effects such as tremors, muscle rigidity, and worsening cognitive impairment.
The researchers advocate for a shift toward person-centered care and non-drug interventions, which focus on understanding and addressing the underlying causes of residents’ behaviors. They recommend alternatives like music, art, and social activities, along with improved pain management and communication strategies, to enhance resident well-being without the adverse effects associated with antipsychotics. Additionally, proper staff training on the risks of these medications and the benefits of alternative therapies has shown promise in improving outcomes, reducing agitation, and enhancing residents’ quality of life. The findings emphasize the need to reconsider antipsychotic use in nursing homes and prioritize holistic approaches to care.
